TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T09159 AS T06314. XX ID T09159 XX DT 31.07.2006 (created); kar. DT 01.04.2015 (updated); sup. CO Copyright (C), QIAGEN. XX FA pitx2a XX SY ARP1A; Otlx2; Pitx2; Ptx-2; Ptx2; PTX2A; RGS; RIEG. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002665 PITX2; HGNC: Pitx2. XX CL C0006; homeo; 3.1.3.19.2.1. XX SZ 271 AA; 30.4 kDa (cDNA) (calc.). XX SQ METNCRKLVSACLQLEKDKSQQGKNEDVGAEDPSKKKRQRRQRTHFTSQQLQQLEATFQR SQ NRYPDMSTREEIAVWTNLTEARVRVWFKNRRAKWRKRERNQQAELCKNGFGPQFNGLMQP SQ YDDMYPGYSYNNWAAKGLTSASLSTKSFPFFNSMNVNPLSSQSMFSPPNSISSMSMSSSM SQ VPSAVTGVPGSSLNSLNNLNNLSSPSLNSAVPTPACPYAPPTPPYVYRDTCNSSLASLRL SQ KAKQHSSFGYASVQKPASNLSACQYAVDRPV XX SC translated from EMBL #U69961 XX FT 1 38 transactivation domain [3]. FT 37 97 PS50071; HOMEOBOX_2. FT 39 95 PS50552; PAX. FT 39 101 SM00389; HOX_1. FT 40 96 PF00046; Homeobox domain. FT 99 271 transactivation domain [3]. FT 228 248 PF03826; OAR domain. FT 233 271 binding activity repression domain [3]. FT 233 271 POU1F1a T00691 interaction domain [3]. FT 233 246 PS50803; OAR. XX SF isoform of PITX2 T02413; XX IN T09508 Mef-2a; human, Homo sapiens. XX MX M01447 V$PITX2_01. MX M00482 V$PITX2_Q2. MX M07056 V$PITX2_Q4. MX M02114 V$PITX2_Q6. MX M08895 V$PITX_Q4. XX BS R10033. BS R15870. BS R11012. BS R11013. BS R11014. BS R15865. BS R15866. BS R27145. BS R27146. BS R66981. BS R11008. BS R11009. BS R11010. BS R11011. BS R15861. BS R04992. XX DR TRANSPATH: MO000083932. DR EMBL: U69961; DR UniProtKB: Q99697-3; XX RN [1]; RE0006808. RX PUBMED: 8944018. RA Semina E. V., Reiter R., Leysens N. J., Alward W. L. M., Small K. W., Datson N. A., Siegle-Bartelt J., Bierke-Nelson D., Bitoun P., Zabel B. U., Carey J. C., Murray J. C. RT Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome RL Nat. Genet. 14:392-399 (1996). RN [2]; RE0016332. RX PUBMED: 9685346. RA Amendt B. A., Sutherland L. B., Semina E. V., Russo A. F. RT The molecular basis of Rieger Syndrome RL J. Biol. Chem. 273:20066-20072 (1998). RN [3]; RE0016846. RX PUBMED: 10490637. RA Amendt B. A., Sutherland L. B., Russo A. F. RT Multifunctional role of the Pitx2 homeodomain protein C-terminal tail. RL Mol. Cell. Biol. 19:7001-7010 (1999). RN [4]; RE0016847. RX PUBMED: 11157981. RA Hjalt T. A., Amendt B. A., Murray J. C. RT PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: implications for the pathology of Rieger syndrome RL J. Cell Biol. 152:545-552 (2001). RN [5]; RE0025062. RX PUBMED: 12692125. RA Ganga M., Espinoza H. M., Cox C. J., Morton L., Hjalt T. A., Lee Y., Amendt B. A. RT PITX2 isoform-specific regulation of atrial natriuretic factor expression: synergism and repression with Nkx2.5. RL J. Biol. Chem. 278:22437-22445 (2003). RN [6]; RE0048085. RX PUBMED: 15466416. RA Toro R., Saadi I., Kuburas A., Nemer M., Russo A. F. RT Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A. RL J. Biol. Chem. 279:52087-52094 (2004). XX //